NeuroMetrix, Inc. Announces Date for First Quarter 2022 Financial Results Conference Call
April 19 2022 - 9:00AM
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to
issue its 2022 first quarter financial results before the opening
of the market on April 26, 2022. The Company will host a conference
call at 8:00 a.m., Eastern Time on April 26, 2022 to discuss its
financial results as well as business developments affecting the
Company.
The conference call may be accessed in the United States by
dialing 844-787-0799 and using the confirmation code 5754338.
Internationally, the conference call may be accessed by dialing
661-378-9630 and using the same confirmation code. The earnings
press release and accompanying condensed financial statements will
be accessible from the Company's website at www.NeuroMetrix.com
under the "Investor Relations" tab.
A replay of the conference call will be available starting two
hours after the call by dialing 855-859-2056, domestically and
404-537-3406, internationally. The confirmation code to access the
replay is 5754338. The replay will be available for one week after
the conference call.
About NeuroMetrix
NeuroMetrix is an innovation-driven company focused on the
development and global commercialization of non-invasive medical
devices for the diagnosis and treatment of pain and neurological
disorders. The Company has three commercial products.
DPNCheck® is a diagnostic device that provides rapid,
point-of-care detection of peripheral neuropathies.
ADVANCE® is a diagnostic device that provides automated,
in-office nerve conduction studies for the evaluation of entrapment
neuropathies. Quell® is a wearable neurostimulation device
indicated for treatment of lower extremity chronic pain. For more
information, visit www.NeuroMetrix.com.
NeuroMetrix, Inc.Thomas T. Higgins, 781-314-2761SVP and Chief
Financial Officerneurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Aug 2024 to Sep 2024
NeuroMetrix (NASDAQ:NURO)
Historical Stock Chart
From Sep 2023 to Sep 2024